About 18 results found for searched term "Ala-Ala-Ala-Ala" (0.16 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M43284 | Ala-Ala-Ala-Ala | Others |
| Ala-Ala-Ala-Ala is a poly-L-alanine (PLA) sequences. | ||
| M51124 | D-{Ala-Ala-Ala-Ala-Ala} | Others |
| D-{Ala-Ala-Ala-Ala-Ala} is a pentapeptide and can be used as an inhibitor of the immunological reactions. | ||
| M52696 | H-D-Ala-D-Ala-D-Ala-D-Ala-OH | Aminopeptidase |
| H-D-Ala-D-Ala-D-Ala-D-Ala-OH is a substrate for D-aminopeptidase. | ||
| M2197 | Sulfasalazine | Ferroptosis |
| Salazopyrin; Azulfidine; Sulphasalazine; SAS; NSC 667219 | ||
| Sulfasalazine is a sulfonamide agent derived from Mesalazine. Sulfasalazine has xC-system inhibitory activity associated with iron death and is primarily used as an anti-inflammatory agent. Sulfasalazine can suppress NF-κB activity. Sulfasalazine is a type 1 ferroptosis inducer. | ||
| M4062 | Punicalagin | Anti-infection |
| Punicalagin is a species from Punica Granatum L. Or polyphenols isolated from the leaves of Terminalia catappa L. Punicalagin is a reversible, noncompetitive 3CLpro inhibitor that inhibits SARS-COV-2 replication in vitro. Punicalagin is an anti-hepatitis B virus (HBV) drug with antioxidant, anti-inflammatory and anticancer effects. Punicalagin has the potential to be used in COVID-19 research. | ||
| M14795 | Z-Ala-Ala-Asn-AMC | Others |
| Cbz-Ala-Ala-Asn-AMC | ||
| Z-Ala-Ala-Asn-AMC (Cbz-Ala-Ala-Asn-AMC) is the legumain substrate. Overexpressed legumain in 293 HEK-Leg cells potently cleaved CBZ-Ala-Ala-Asn-AMC. | ||
| M20007 | Methyl β-D-Galactopyranoside | Metabolite/Endogenous Metabolite |
| Methylgalactoside | ||
| Methyl Β-D-galactopyranoside (Methyl β-D-Galactopyranoside ) is an endogenous metabolite. Inside cells, methyl-Β-D-galactopyranoside is mainly located in the cytoplasm. Outside the human body, methyl-Β-D-galactopyranoside can be found in cereals and cereal products. | ||
| M24827 | Talacotuzumab | IL Receptor/Related |
| JNJ 56022473; CSL 362 | ||
| Talacotuzumab (JNJ 56022473; CSL 362) is an IgG1-type fully humanized, CD123-neutralizing monoclonal antibody containing a modified Fc structure. Talacotuzumab has KDs of 0.43 nM, 188 nM, 46 nM, 16.8 nM for CD123, CD32b/c, CD16-158F, CD16-158V, respectively. Talacotuzumab inhibits IL-3 binding to CD123, antagonizing IL-3 signaling in target cells. Talacotuzumab has mutated the Fc region to increase affinity for CD16 (FcγRIIIa), thereby enhancing antibody-dependent cell-mediated cytotoxicity (ADCC). Talacotuzumab is highly effective in vivo reducing leukemic cell growth in acute myeloid leukemia (AML) xenograft mouse models. | ||
| M27978 | Aurothiomalate sodium | PKC |
| Aurothiomalate sodium is a potent and selective oncogenic PKCι signaling inhibitor. Aurothiomalate sodium inhibits tumor cell proliferation and not cell apoptosis. Aurothiomalate sodium is a potent thioredoxin reductase (TrxR) inhibitor. Aurothiomalate sodium, an anti-rheumatoid agent, exhibits potent anti-tumor activity. | ||
| M28348 | Nogalamycin | DNA/RNA Synthesis |
| Nogalamycin is an anthracyclinone antibiotic. Nogalamycin is a potent antibiotic against Gram-positive bacteria, also has cytotoxicity against certain tumor cells. Nogalamycin is produced by Streptomyces nogalater var. Nogalater. Nogalamycin selectively inhibits RNA synthesis after binding to DNA template. Nogalamycin can be used for researching anticancer. | ||
| M28506 | Alatrofloxacin | DNA/RNA Synthesis |
| Alatrofloxacin, the parenteral proagent of Trovafloxacin, is a fluoronaphthyridone which contains an L-alanyl-L-alanyl salt. Alatrofloxacin functions similar to other fluoroquinolone antibiotics in that it not only has antibiotic activity to kill invading organisms by interfering with DNA synthesis, it possesses immunosuppressive activity. | ||
| M30406 | Balanol | PKA |
| Ophiocordin; Azepinostatin | ||
| Balanol (Ophiocordin; Azepinostatin) is a potent and ATP competitive PKC/PKA inhibitor against human PKC isozymes α, β-I, β-II, γ, δ, ε, η (IC50s=4-9 nM) and ζ (IC50=150 nM). Balanol also blocks the phosphorylation of cyclic AMP response element-binding protein (CREB) and myristoylated alanine-rich C kinase substrate (MARCKS). Balanol can be isolated from the fungus Verticillium balanoides. | ||
| M38782 | Antimalarial agent 12 | Parasite |
| Antimalarial agent 12 is a potent antimalarial agent. Antimalarial agent 12 shows growth inhibition on P. falciparum Dd2 Strain (EC50=155 nM), 3D7 strain (EC50=136 nM). Antimalarial agent 12 has CC50 values of 10,000 to 50,000 nM for HEK-293 and hPHep cell lines. | ||
| M45369 | β-Galactosidase | Senolytics |
| EC 3.2.1.23 | ||
| β-Galactosidase is a glycoside hydrolase that hydrolyzes the β-glycosidic bond formed between galactose and its organic part. In Escherichia coli, the lacZ gene is the structural gene for β-galactosidase and can be used as part of the lac manipulator of the inducible system. β-Galactosidase hydrolyzes lactose to form glucose and galactose, which enter glycolysis, and also catalyzes the transgalactosylation of lactose to isolactose, which can be cleaved to monosaccharides. | ||
| M50605 | H-AAAAAA-OH | Others |
| Ala-Ala-Ala-Ala-Ala-Ala is a hexapeptide composed of six alanine amino acid residues. | ||
| M51221 | Ala-D-γ-Glu-Lys-D-Ala-D-Ala | Others |
| Ala-D-γ-Glu-Lys-D-Ala-D-Ala is the pentapeptide tail of the peptidoglycan precursor UDPMurNAc-l-Ala-γ-d-Glu-l-Lys(Gly)(5)-d-Ala-d-Ala. | ||
| M51764 | Ala-Ala-Ala | Amino Acid Derivatives |
| Ala-Ala-Ala is an alanine derivative. | ||
| M54355 | M871 | Neuropeptide Receptor |
| M871 (Galanin-(2-13)-Glu-His-(Pro)3-(Ala-Leu)2-Ala-amide) is a selective galanin receptor type 2 (GalR2) antagonist. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
